Icu Medical (ICUI) Gains from Investment Securities (2017 - 2024)
Icu Medical's (ICUI) quarterly Gains from Investment Securities came in at -$1.4 million in Q4 2024, up 64.72% on a YoY basis from -$854780.7 in Q1 2024, and up 64.33% quarter-over-quarter from -$3.9 million in Q3 2024.
Powered by 
Analysis
Icu Medical (ICUI) Gains from Investment Securities (2017 - 2024) Analysis & Trends
Icu Medical (ICUI) has reported Gains from Investment Securities for 7 consecutive years, with -$1.4 million the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Gains from Investment Securities rose 64.72% year-over-year to -$1.4 million; the trailing twelve-month figure through Sep 2025 stood at -$1.4 million (up 82.36% YoY), and the FY2024 full-year result was -$5.4 million, up 66.77% from the prior year.
- Gains from Investment Securities improved to -$1.4 million in Q4 2024 per ICUI's latest filing, from -$3.9 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $4.3 million in Q3 2020 and bottomed at -$27.2 million in Q2 2022.
- Historically, Gains from Investment Securities has averaged -$3.2 million across 4 years, with a median of -$769000.0 in 2022.
- The sharpest annual moves came in 2020 and 2023: Gains from Investment Securities soared 2250.0% in 2020, then sank 376.25% in 2023.
- Over 4 years, Gains from Investment Securities stood at $2.0 million in 2020, then sank by 141.9% to -$838000.0 in 2022, then tumbled by 376.25% to -$4.0 million in 2023, then surged by 64.72% to -$1.4 million in 2024.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered -$1.4 million, -$3.9 million, and -$339000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn |
| 10 | Icu Medical | 3.82 Bn | 3.52 Bn | 235.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -1.41 Mn |
| Sep 30, 2024 | -3.95 Mn |
| Jun 30, 2024 | -339,000.00 |
| Mar 31, 2024 | 295,000.00 |
| Dec 31, 2023 | -3.99 Mn |
| Sep 30, 2023 | -15.57 Mn |
| Jun 30, 2023 | 4.02 Mn |
| Mar 31, 2023 | -700,000.00 |
| Dec 31, 2022 | -838,000.00 |
| Sep 30, 2022 | -4.06 Mn |
| Jun 30, 2022 | -27.19 Mn |
| Dec 31, 2020 | 2.00 Mn |
| Sep 30, 2020 | 4.30 Mn |
| Jun 30, 2020 | 2.70 Mn |
| Sep 30, 2019 | -200,000.00 |
| Jun 30, 2019 | -39.50 Mn |
| Mar 31, 2019 | -7.70 Mn |
| Dec 31, 2018 | -100,000.00 |
| Sep 30, 2018 | 18.50 Mn |
| Jun 30, 2018 | 6.00 Mn |